Home Cart 0 Sign in  
X

[ CAS No. 41288-96-4 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 41288-96-4
Chemical Structure| 41288-96-4
Chemical Structure| 41288-96-4
Structure of 41288-96-4 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 41288-96-4 ]

Related Doc. of [ 41288-96-4 ]

Alternatived Products of [ 41288-96-4 ]

Product Details of [ 41288-96-4 ]

CAS No. :41288-96-4 MDL No. :MFCD00234050
Formula : C5H4ClNO Boiling Point : -
Linear Structure Formula :- InChI Key :KVCOOWROABTXDJ-UHFFFAOYSA-N
M.W : 129.54 Pubchem ID :819821
Synonyms :

Calculated chemistry of [ 41288-96-4 ]

Physicochemical Properties

Num. heavy atoms : 8
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.0
Num. rotatable bonds : 0
Num. H-bond acceptors : 2.0
Num. H-bond donors : 1.0
Molar Refractivity : 31.27
TPSA : 33.12 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.08 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.13
Log Po/w (XLOGP3) : 1.42
Log Po/w (WLOGP) : 1.44
Log Po/w (MLOGP) : 0.4
Log Po/w (SILICOS-IT) : 1.61
Consensus Log Po/w : 1.2

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.09
Solubility : 1.05 mg/ml ; 0.00808 mol/l
Class : Soluble
Log S (Ali) : -1.72
Solubility : 2.47 mg/ml ; 0.019 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -2.03
Solubility : 1.21 mg/ml ; 0.00938 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.43

Safety of [ 41288-96-4 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 41288-96-4 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 41288-96-4 ]
  • Downstream synthetic route of [ 41288-96-4 ]

[ 41288-96-4 ] Synthesis Path-Upstream   1~25

  • 1
  • [ 109-09-1 ]
  • [ 41288-96-4 ]
  • [ 6636-78-8 ]
Reference: [1] Heterocyclic Communications, 2001, vol. 7, # 5, p. 501 - 506
  • 2
  • [ 188057-24-1 ]
  • [ 41288-96-4 ]
YieldReaction ConditionsOperation in experiment
96% With potassium carbonate In methanol at 20℃; for 2 h; 2-Chloro-5-acetoxypyridine (21.66 g, 126 mmol) was dissolved in 300 mL of methanol and K2CO3(8.70 g, 63 mmol) was added. The reaction was stirred at room temperature for approx. 2 h, then concentrated in vacuo. The residue was diluted with diethyl ether and water, and the aqueous layer was adjusted to neutral pH by the addition of 1N aqueous HCl. Following extraction with diethyl ether, the organics were combined, washed with a solution of saturated aqueous NaCl, dried with MgSO4, and concentrated in vacuo. The resulting yellow solid (15.58 g, 96percent) was used without further purification.
96% With hydrogenchloride; potassium carbonate In methanol 11b.
2-chloro-5-hydroxypyridine
5-Acetoxy-2-chloropyridine (11.1 g, 64.7 mmol) from step 11a was dissolved in MeOH at ambient temperature and solid potassium carbonate (4.47 g, 32.4 mmol) was added.
After stirring for 2 h, the volatiles were removed in vacuo and the residue was diluted with Et2 O and H2 O.
The aqueous phase was neutralized to pH 7 by the addition of 1 N aqueous HCl.
The layers were separated and the aqueous phase was extracted twice with Et2 O.
The combined organic extracts were dried (MgSO4) and concentrated to provide the title compound as a white solid (8.03 g, 96percent): mp 155° C.; 1 H NMR (CD3 OD, 300 MHz) δ 7.20-7.28 (m, 2H), 7.88 (m, 1H); MS (CI/NH3) m/z: 130,132 (M+H)+; 147,149 (M+NH4)+.
91% at 20℃; for 20 h; 3) 2-Chloro-5-hydroxypyridine; Potassium carbonate (400 mg) was added to a solution of the 5-acetoxy-2-chloropyridine (10 g) in methanol (200 ml), and the mixture was stirred at room temperature for 20 hours. The reaction solvent was evaporated under reduced pressure, and the residue was purified by chromatography on silica gel (ethyl acetate) to give 2-chloro-5-hydroxypyridine (6.86 g, 91percent) as a solid. 1H-NMR (400 MHz, DMSO-d6)δ: 7.24 (1H, dd, J = 8.8, 2.9 Hz), 7.29 (1H, d, J = 8.8 Hz), 7.91 (1H, d, J = 2.9 Hz), 10.22 (1H, br). LC-MSm/z: 130 (M+H)+.
82% With potassium carbonate In methanol at 20℃; for 2 h; To a solution of acetic acid 6-chloro-pyridin-3-yl ester (1.67 g, 9.8 MMOL) in methanol (10 mL) was added potassium carbonate (676 mg, 4.9 MMOL), and the resulting reaction stirred at ambient temperature for 2 hours. The reaction was concentrated to an oily solid which was partitioned between water and diethyl ether. The water layer was neutralized with 3N HCI (3.7 mL), and extracted with diethyl ether (1X). The organics were combined, washed with brine, dried over sodium sulfate, and concentrated in vacuo to give the above named compound as a tan solid (1.04 g, 82percent).

Reference: [1] Patent: US6696439, 2004, B1, . Location in patent: Page column 20
[2] Patent: US6001849, 1999, A,
[3] Tetrahedron Letters, 2003, vol. 44, # 4, p. 725 - 728
[4] Patent: EP1698626, 2006, A1, . Location in patent: Page/Page column 24
[5] Patent: WO2004/72072, 2004, A1, . Location in patent: Page 85
[6] Tetrahedron Asymmetry, 1998, vol. 9, # 16, p. 2791 - 2794
[7] Patent: US6313127, 2001, B1,
  • 3
  • [ 444120-91-6 ]
  • [ 41288-96-4 ]
Reference: [1] Tetrahedron, 2005, vol. 61, # 6, p. 1417 - 1421
  • 4
  • [ 1235099-38-3 ]
  • [ 41288-96-4 ]
Reference: [1] Journal of Organic Chemistry, 2011, vol. 76, # 2, p. 623 - 630
  • 5
  • [ 5350-93-6 ]
  • [ 41288-96-4 ]
Reference: [1] European Journal of Inorganic Chemistry, 2015, vol. 2015, # 28, p. 4666 - 4677
[2] Chemische Berichte, 1992, vol. 125, # 5, p. 1131 - 1140
[3] Tetrahedron Asymmetry, 1998, vol. 9, # 16, p. 2791 - 2794
[4] Patent: US6313127, 2001, B1,
  • 6
  • [ 444120-94-9 ]
  • [ 41288-96-4 ]
Reference: [1] Tetrahedron, 2005, vol. 61, # 6, p. 1417 - 1421
  • 7
  • [ 109-09-1 ]
  • [ 41288-96-4 ]
  • [ 6636-78-8 ]
Reference: [1] Heterocyclic Communications, 2001, vol. 7, # 5, p. 501 - 506
  • 8
  • [ 444120-94-9 ]
  • [ 41288-96-4 ]
  • [ 1693-83-0 ]
Reference: [1] Chemistry - A European Journal, 2013, vol. 19, # 48, p. 16342 - 16356
  • 9
  • [ 69045-79-0 ]
  • [ 41288-96-4 ]
Reference: [1] Synthetic Communications, 2000, vol. 30, # 22, p. 4093 - 4096
  • 10
  • [ 211377-86-5 ]
  • [ 41288-96-4 ]
Reference: [1] Synthetic Communications, 2000, vol. 30, # 22, p. 4093 - 4096
  • 11
  • [ 1360056-04-7 ]
  • [ 41288-96-4 ]
Reference: [1] Organic Process Research and Development, 2013, vol. 17, # 5, p. 876 - 880
  • 12
  • [ 462-34-0 ]
  • [ 41288-96-4 ]
Reference: [1] Organic Process Research and Development, 2013, vol. 17, # 5, p. 876 - 880
  • 13
  • [ 41288-96-4 ]
  • [ 74-88-4 ]
  • [ 139585-48-1 ]
YieldReaction ConditionsOperation in experiment
98% With sodium methylate In methanol; N,N-dimethyl-formamide at 20℃; for 1.5 h; 4) 2-Chloro-5-methoxypyridine; To a solution of the 2-chloro-5-hydroxypyridine (1.30 g) and methyl iodide (1.25 ml) in N,N-dimethylformamide (26 ml) was added dropwise 28percent solution of sodium methoxide in methanol (2.0 ml), and the mixture was stirred at room temperature for 1.5 hours. Saturated aqueous ammonium chloride and ethyl acetate were added to the reaction liquid, then the phases were separated. The organic layer was washed with brine and dried over anhydrous magnesium sulfate. After filtration, the solvent was evaporated under reduced pressure, and the residue was purified by chromatography on silica gel (hexane-ethyl acetate) to give 2-chloro-5-methoxypyridine (1.40 g, 98percent) as a solid. 1H-NMR (400 MHz, CDCl3)δ: 3.85 (3H, s), 7.17-7.25 (2H, m), 8.05 (1H, d, J = 2.9 Hz). LC-MSm/z: 144 (M+H)+.
84% With potassium carbonate In N,N-dimethyl-formamide at 20℃; for 18 h; Inert atmosphere Example 7; Synthesis of 1-[2-(5-hydroxy-5-trifluoromethyl-5-H-indeno[1,2-b]pyridin-3-yloxy)-ethyl]-pyrrolidin-2-one (compound No. 430); Step 1; 2-chloro-5-methoxy-pyridine; Under a nitrogen atmosphere, potassium carbonate (5.52 g) was added to a mixture of 2-chloro-5-hydroxy-pyridine (2.591 g), methyl iodide (1.50 ml) and dimethylformamide (26 ml), and the mixture was stirred at room temperature for 18 hr. To the reaction mixture was added ethyl acetate and the mixture was placed in a separatory funnel. The organic layer was washed 4 times with aqueous ammonium chloride, dried over anhydrous sodium sulfate, and filtered. The filtrate was concentrated under reduced pressure to give the title compound (2.403 g, 84percent).1H-NMR (CDCl3) δ: 8.07 (1H, d, J=3.0 Hz), 7.24 (1H, dd, J=8.8, 0.7 Hz), 7.20 (1H, dd, J=8.6, 3.0 Hz), 3.87 (3H, s).
Reference: [1] Patent: EP1698626, 2006, A1, . Location in patent: Page/Page column 24
[2] Patent: US2010/240634, 2010, A1, . Location in patent: Page/Page column 74
[3] European Journal of Inorganic Chemistry, 2015, vol. 2015, # 28, p. 4666 - 4677
[4] Journal of Medicinal Chemistry, 2014, vol. 57, # 6, p. 2462 - 2471
[5] Chemische Berichte, 1992, vol. 125, # 5, p. 1131 - 1140
  • 14
  • [ 41288-96-4 ]
  • [ 89809-63-2 ]
Reference: [1] Journal of Medicinal Chemistry, 2014, vol. 57, # 6, p. 2462 - 2471
  • 15
  • [ 41288-96-4 ]
  • [ 188057-26-3 ]
YieldReaction ConditionsOperation in experiment
95% With iodine; sodium carbonate In water at 20℃; for 48 h; A solution of the above material (15.48 g, 119 mmol) and Na2CO3 (26.56 g, 251 mmol) in water (300 mL) was charged with iodine (30.3 g, 119 mmol). The reaction mixture was stirred at room temperature until the iodine color disappeared, approx. 48 h. The solution was adjusted to pH =5 with 1 N aqueous HCl, and extracted with ethyl acetate. The organic layers were washed with saturated aqueous NaCl, dried over Na2SO4, and concentrated in vacuo. The resulting white solid was recrystallized from methanol to provide 17.8 g (95percent) of the title compound. MS(m/e): 256 (M+); Calculated for C5H3ClINO: Theory: C, 23.51; H, 1.18; N, 5.48; Found: C, 23.72; H, 1.19; N, 5.45.
94% With iodine; sodium carbonate In water at 25℃; for 2 h; Inert atmosphere To a stirred solution of 2-chloro-5-hydroxypyridine (6.0 g, 46.3 mmol) in H20 (80 mL) were added Na2C03 (10.3 g, 97.3 mmol) and I2 (11.8 g, 46.3 mmol). The resulting mixture was stirred at 25 °C under N2 for 2 h. Then it was neutralized by HC1 (1M, aprox. 50 mL) to pH=7 and extracted with EtOAc (3x110 mL). The organic extracts were washed with brine (150 mL), dried over Na2S04, filtered, and the solvent was evaporated. The product was obtained as a pale yellow solid (11.1 g, 94 percent). 1H NMR (500 MHz, DMSO-d6) δ 11.10 (s, 1H); 7.30 (d, J = 8.40 Hz, 1H); 7.18 (d, J = 8.40 Hz, 1H). I3C NMR (126 MHz, DMSO-d6) S 153.9, 138.1, 124.0, 123.9, 107.7. HRMS (APCI): calcd. for C5H4C1IN0 [M+H]+ = 255.9021; found [M+H]+ = 255.9018
75% With iodine; sodium carbonate In tetrahydrofuran; water at 20℃; for 4 h; Step 1: 6-chloro-2-iodopyridin-3-ol To solution of 6-chloro-pyridin-3-ol (112 g, 868 mmol) in THF (800 mL)/Water (800 mL) was added sodium carbonate (92.0 g, 1.736 mol;) and iodine (244.2 g, 1.04 mol;). The reaction mixture was stirred rt 4 h. The aqueous layer containing product was separated and washed with hexane (400 mL.x.2). The aqueous layer was neutralized to pH=7 with HCl and then extracted EtOAc (500 mL.x.4). The combined organic layers were dried over Na2SO4, and filtered. The filtrate was concentrated to the crude product, which was washed with EtOAc to afford 163 g of 6-chloro-2-iodopyridin-3-ol, yield: 75percent. 1H NMR (DMSO, 400 MHz): δ11.13 (s, 1H, OH), 7.31 (dd, J=8.4, 12.8 Hz, 2H).
70.9% With iodine; sodium carbonate In water at 20℃; for 2 h; Inert atmosphere 6-chloropyridin-3-ol (5.0 g, 38.60 mmol) was dissolved in water (50 mL) and placed under an N2 atmosphere. Na2CO3 (8.2 g, 77.37 mmol) was added followed by iodine (9.8 g, 38.81 mmol). The reaction mixture was stirred at room temperature for 2 h. The mixture was poured into 1 M Na25203 and extracted with EtOAc. The combined organic phases were washed with brine, dried over Na2504 and concentrated to give the product of 6-chloro-2-iodopyridin-3-ol (7.0 g, yield: 70.9percent). ‘H-NMR (CDC13, 400 MHz) 7.17 (d, J= 8.4 Hz, 1H), 7.06 (d, J 8.4 Hz, 1H). MS (M+H): 256 /258.
70.9% With iodine; sodium carbonate In water at 20℃; for 2 h; Inert atmosphere Step 12-Synthesis of 6-chloro-2-iodopyridin-3-ol
6-chloropyridin-3-ol (5.0 g, 38.6 mmol) was dissolved in water (50 mL) and placed under an N2 atmosphere. Na2CO3 (8.2 g, 77.4 mmol) was added followed by iodine (9.8 g, 38.8 mmol).
The reaction mixture was stirred at room temperature for 2 hours.
The mixture was poured into 1M Na2S2O3 and extracted with EtOAc.
The combined organic phases were washed with brine, dried over Na2SO4 and concentrated to provide the product of 6-chloro-2-iodopyridin-3-ol (7.0 g, yield: 70.9percent).
1H-NMR (CDCl3, 400 MHz) δ 7.17 (d, J=8.4 Hz, 1H), 7.06 (d, J=8.4 Hz, 1H). MS (M+H)+: 256/258.
70.9% With iodine; sodium carbonate In water at 25℃; for 2 h; Inert atmosphere 6-chloropyridin-3-ol (5.0 g, 38.6 mmol) was dissolved in water (50 mL) and placed under an N2 atmosphere. Na2C03 (8.2 g, 77.4 mmol) was added followed by iodine (9.8 g, 38.8 mmol) The reaction mixture was stirred at room temperature for 2 hours. The mixture was poured into 1M Na2S203 and extracted with EtOAc. The combined organic phases were washed with brine, dried over Na2S04 and concentrated to give the product of 6-chloro-2-iodopyridin-3-ol (7.0 g, yield: 70.9percent). 1H- MR (CDC13, 400 MHz) δ 7.17 (d, J= 8.4 Hz, 1H), 7.06 (d, J= 8.4 Hz, 1H). MS (M+H)+: 256 / 258.
70.9% With iodine; sodium carbonate In water at 20℃; for 2 h; Inert atmosphere 6-chloropyridin-3-ol (5.0 g, 38.60 mmol) was dissolved in water (50 mL) andplaced under an N2 atmosphere. Na2C03 (8.2 g, 77.37 mmol) was added followed by iodine (9.8g, 38.81 mmol). The reaction mixture was stirred at room temperature for 2 h. The mixture waspoured into 1 M Na2S20 3 and extracted with EtOAc. The combined organic phases were washedwith brine, dried over Na2S04 and concentrated to give the product of 6-chloro-2-iodopyridin-3-20 ol (7.0 g, yield: 70.9percent). 1H-NMR (CDCh, 400 MHz) 8 7.17 (d, J = 8.4 Hz, 1H), 7.06 (d, J = 8.4Hz, 1H). MS (M+Ht: 256 /258.
70.9% With iodine; sodium carbonate In water at 20℃; for 2 h; Inert atmosphere Compound 1 (5.0 g, 38.60 mmol) was dissolved in water (50 mL) and placed under an N2 atmosphere. Na2CO3 (8.2 g, 77.37 mmol) was added followed by iodine (9.8 g, 38.81 mmol). The reaction mixture was stirred at room temperature for 2 h. The mixture was poured into 1M Na2S2O3 and extracted with EtOAc. The combined organic phases were washed with brine, dried over Na2SO4 and concentrated to give the product of Compound 2 (7.0 g, yield: 70.9percent). 1H-NMR (CDCl3, 400 MHz) d 7.17 (d, J = 8.4 Hz, 1H), 7.06 (d, J = 8.4 Hz, 1H).
2.04 g With iodine; sodium carbonate In tetrahydrofuran; water at 20℃; for 1.5 h; Reference Example 15 [Step a] To a mixed solution of compound 1 (1.00 g, 7.71 mmol) and sodium carbonate (1.71 g, 16.2 mmol) in tetrahydrofuran (5.00 mL) and water (5.00 mL) was added iodine (2.94 g, 16.2 mmol) in 3 portions at room temperature, and the mixture was stirred for 1.5 hr. The reaction solution was neutralized with 1 M-hydrochloric acid, and extracted with ethyl acetate. The organic layer was washed with aqueous sodium thiosulfate solution, dried over anhydrous sodium sulfate, filtered, and concentrated to give compound 2 (2.04 g). MS(ESI)m/z: 256 (M+1)+

Reference: [1] Tetrahedron Letters, 2003, vol. 44, # 4, p. 725 - 728
[2] Patent: US6696439, 2004, B1, . Location in patent: Page column 20
[3] Patent: WO2015/165428, 2015, A1, . Location in patent: Page/Page column 18
[4] Organic Process Research and Development, 2016, vol. 20, # 7, p. 1227 - 1238
[5] Patent: US2011/76291, 2011, A1, . Location in patent: Page/Page column 148
[6] Journal of Medicinal Chemistry, 2017, vol. 60, # 2, p. 627 - 640
[7] Patent: WO2014/123793, 2014, A1, . Location in patent: Page/Page column 37
[8] Patent: US2014/213571, 2014, A1, . Location in patent: Paragraph 0802
[9] Patent: WO2014/121418, 2014, A1, . Location in patent: Page/Page column 36
[10] Patent: WO2014/121416, 2014, A1, . Location in patent: Page/Page column 37
[11] Tetrahedron Letters, 2017, vol. 58, # 14, p. 1373 - 1375
[12] Patent: EP3135667, 2017, A1, . Location in patent: Paragraph 0434-0435
[13] Patent: WO2004/39753, 2004, A2, . Location in patent: Page 85
  • 16
  • [ 41288-96-4 ]
  • [ 497-19-8 ]
  • [ 188057-26-3 ]
Reference: [1] Patent: US6001849, 1999, A,
  • 17
  • [ 41288-96-4 ]
  • [ 100-39-0 ]
  • [ 84611-43-8 ]
YieldReaction ConditionsOperation in experiment
100% With potassium carbonate In N,N-dimethyl-formamide at 60℃; for 18 h; 6-chloropyridin-3-ol (1.0 g),Benzyl bromide (1.5 g) and potassium carbonate (2.4 g)Was dissolved in DMF (40 mL) and stirred at 60 ° C. for 18 hours.After filtering the reaction solution,The solvent of the obtained filtrate was distilled off under reduced pressure to obtain a residue,Purification by silica gel column chromatography (hexane-ethyl acetate)5- (benzyloxy) -2-chloropyridine1.3 g (yield quant.) Was obtained.
79% With caesium carbonate In N,N-dimethyl-formamide Example 29A
5-(benzyloxy)-2-chloropyridine
2-Chloro-5-hydroxypyridine (2.6 g, 20 mmol) and cesium carbonate (7.2 g, 22 mmol) in 8 mL of DMF were treated with benzyl bromide (2.6 mL).
After stirring at 23° C. for 6 hours, the reaction mixture was diluted with water, adjusted to pH 7 with saturated aqueous NaH2PO4, and extracted with dichloromethane.
The organic extract was dried over Na2SO4, filtered and the filtrate concentrated under reduced pressure.
The residue was purified by flash chromatography (eluding with CH2Cl2) to provide the title compound as a white solid (3.44 g, 79percent).
mp <50° C.; Rf=0.4 (CH2Cl2); MS 220 (M+H)+; 1H NMR (300 MHz, DMSO-d6) δ8.20 (d, 1H, J=2.7 Hz), 7.55 (dd, 1H, J=9, 2.7 Hz), 7.3-7.5 (m, 6 H), 5.19 (s, 2H).
79% With caesium carbonate In N,N-dimethyl-formamide Example 29A
5-(benzyloxy)-2-chloropyridine
2-Chloro-5-hydroxypyridine (2.6 g, 20 mmol) and cesium carbonate (7.2 g, 22 mmol) in 8 mL of DMF were treated with benzyl bromide (2.6 mL).
After stirring at 23° C. for 6 hours, the reaction mixture was diluted with water, adjusted to pH 7 with saturated aqueous NaH2PO4, and extracted with dichloromethane.
The organic extract was dried over Na2SO4, filtered and the filtrate concentrated under reduced pressure.
The residue was purified by flash chromatography (eluding with CH2Cl2) to provide the title compound as a white solid (3.44 g, 79percent).
mp<50° C.; Rf=0.4 (CH2Cl2); MS 220 (M+H)+; 1H NMR (300 MHz, DMSO-d6) δ 8.20 (d, 1H, J=2.7 Hz), 7.55 (dd, 1H, J=9, 2.7 Hz), 7.3-7.5 (m, 6H), 5.19 (s, 2H).
79% With caesium carbonate In N,N-dimethyl-formamide EXAMPLE 29A
5-(benzyloxy)-2-chloropyridine
2-Chloro-5-hydroxypyridine (2.6 g, 20 mmol) and cesium carbonate (7.2 g, 22 mmol) in 8 mL of DMF were treated with benzyl bromide (2.6 mL).
After stirring at 23° C. for 6 hours, the reaction mixture was diluted with water, adjusted to pH 7 with saturated aqueous NaH2PO4, and extracted with dichloromethane.
The organic extract was dried over Na2SO4, filtered and the filtrate concentrated under reduced pressure.
The residue was purified by flash chromatography (eluding with CH2Cl2) to provide the title compound as a white solid (3.44 g, 79percent).
mp <50° C.; Rf=0.4 (CH2Cl2); MS 220 (M+H)+; 1H NMR (300 MHz, DMSO-d6) δ8.20 (d, 1H, J=2.7 Hz), 7.55 (dd, 1H, J=9, 2.7 Hz), 7.3-7.5 (m, 6H), 5.19 (s, 2H).
79% With caesium carbonate In N,N-dimethyl-formamide EXAMPLE 29A
5-(benzyloxy)-2-chloropyridine
2-Chloro-5-hydroxypyridine (2.6 g, 20 mmol) and cesium carbonate (7.2 g, 22 mmol) in 8 mL of DMF were treated with benzyl bromide (2.6 mL).
After stirring at 23° C. for 6 hours, the reaction mixture was diluted with water, adjusted to pH 7 with saturated aqueous NaH2PO4, and extracted with dichloromethane.
The organic extract was dried over Na2SO4, filtered and the filtrate concentrated under reduced pressure.
The residue was purified by flash chromatography (eluding with CH2Cl2) to provide the title compound as a white solid (3.44 g, 79percent).
mp <50° C.; Rf=0.4 (CH2Cl2); MS 220 (M+H)+; 1H NMR (300 MHz, DMSO-d6) δ 8.20 (d, 1H, J=2.7 Hz), 7.55 (dd, 1H, J=9, 2.7 Hz), 7.3-7.5 (m, 6H), 5.19 (s, 2H).
79% With caesium carbonate In N,N-dimethyl-formamide Example 29A
5-(benzyloxy)-2-chloropyridine
2-Chloro-5-hydroxypyridine (2.6 g, 20 mmol) and cesium carbonate (7.2 g, 22 mmol) in 8 mL of DMF were treated with benzyl bromide (2.6 mL).
After stirring at 23° C. for 6 hours, the reaction mixture was diluted with water, adjusted to pH 7 with saturated aqueous NaH2PO4, and extracted with dichloromethane.
The organic extract was dried over Na2SO4, filtered and the filtrate concentrated under reduced pressure.
The residue was purified by flash chromatography (eluding with CH2Cl2) to provide the title compound as a white solid (3.44 g, 79percent).
mp<50° C.; Rf=0.4 (CH2Cl2); MS 220 (M+H)+; 1H NMR (300 MHz, DMSO-d6) δ 8.20 (d, 1H, J=2.7 Hz), 7.55 (dd, 1H, J=9, 2.7 Hz), 7.3-7.5 (m, 6 H), 5.19 (s, 2H).
8000 mg With potassium carbonate In N,N-dimethyl-formamide at 60℃; for 16 h; To a mixture of A-36 (5 g, 38.6 mmol) and K2C03 (10.65 g, 77.2 mmol) in DMF (40 mL) was added bromomethylbenzene (5.04 mL, 42.46 mmol). The reaction mixture was heated to 60 °C and stirred for 16 hours. After cooling, the mixture was diluted with H20 (150 mL), and the mixture was extracted with EtOAc (100 mL x 2). The combined organic phase was washed with brine (80 mL), dried over Na2SC>4, filtered and concentrated to afford A-37 (8000 mg, 36.42 mmol), which was used directly in next step. 1H NMR (CDC13, 400MHz) δH = 8.14 (d, 1H), 7.44 - 7.34 (m, 5H), 7.26 - 7.21 (m, 2H), 5.11 (s, 2H).

Reference: [1] Patent: JP2017/171619, 2017, A, . Location in patent: Paragraph 0233; 0235
[2] Patent: US2003/162790, 2003, A1,
[3] Patent: US2002/169166, 2002, A1,
[4] Patent: US2002/169167, 2002, A1,
[5] Patent: US2004/127504, 2004, A1,
[6] Patent: US6960589, 2005, B2,
[7] Journal of Medicinal Chemistry, 2006, vol. 49, # 25, p. 7450 - 7465
[8] Patent: US2003/229094, 2003, A1, . Location in patent: Page 113
[9] Patent: US2004/29887, 2004, A1,
[10] Patent: WO2018/148745, 2018, A1, . Location in patent: Page/Page column 110, 111
  • 18
  • [ 41288-96-4 ]
  • [ 100-44-7 ]
  • [ 84611-43-8 ]
Reference: [1] Patent: US4406907, 1983, A,
[2] Patent: EP1156045, 2001, A1,
[3] Patent: EP1243268, 2002, A1,
[4] Patent: WO2009/38974, 2009, A1, . Location in patent: Page/Page column 74
  • 19
  • [ 41288-96-4 ]
  • [ 630120-99-9 ]
Reference: [1] Journal of Medicinal Chemistry, 2006, vol. 49, # 25, p. 7450 - 7465
  • 20
  • [ 41288-96-4 ]
  • [ 1206972-45-3 ]
Reference: [1] Patent: US2015/307465, 2015, A1,
  • 21
  • [ 41288-96-4 ]
  • [ 75-03-6 ]
  • [ 856851-48-4 ]
YieldReaction ConditionsOperation in experiment
90% With potassium carbonate In N,N-dimethyl-formamide at 0 - 40℃; for 2 h; To a stirred solution of 6-chloropyridin-3-ol (3.0 g, 23.2 mmol) in N,N-dimethylformamide (30 mL) was added iodoethane (4.33 g, 27.8 mmol, 2.22 mL), and potassium carbonate (9.60 g, 69.6 mmol) at 0°C. The reaction was warmed and stirred at 40 00 for 2 h. The reaction mixture was quenched by addition of water (30 mL) then the mixture was extracted with ethyl acetate (60 mL x 3). The combined organicphases were washed with saturated aqueous sodium chloride solution (30 mL), dried over anhydrous sodium sulfate, filtered and concentrated to give 2-chloro-5-ethoxypyridine (3.30 g, 20.9 mmol, 90 percent) as a yellow solid. 1H NMR (400 MHz, ODd3) O 7.97(d, J2.9 Hz, 1H), 7.17- 7.07(m, 2H), 3.99 (q, J7.0 Hz, 2H), 1 .36 (t, J7.0 Hz, 3H).
Reference: [1] Patent: WO2018/81167, 2018, A1, . Location in patent: Page/Page column 231; 232; 241
  • 22
  • [ 41288-96-4 ]
  • [ 1060804-53-6 ]
Reference: [1] Patent: WO2013/127268, 2013, A1,
[2] Journal of Medicinal Chemistry, 2016, vol. 59, # 18, p. 8345 - 8368
  • 23
  • [ 41288-96-4 ]
  • [ 1885-46-7 ]
  • [ 1206980-28-0 ]
YieldReaction ConditionsOperation in experiment
74% With potassium hydroxide In water; acetonitrile at 20℃; for 0.5 h; General procedure: To a vigorously stirred solution of 2-chloro-6-hydroxypyridine(0.13 g, 1.0 mmol) in acetonitrile (2 mL) at room temperature was added a 6 M aqueous solution of potassium hydroxide (2 mL). Difluoromethyltriflate (0.38 mL, 3.0 mmol, 3 equiv.) was added dropwiseto the reaction mixture which was maintained at room temperature by means of a water bath (the reaction is exothermic), and the medium was stirred for 30 min. The mixture was diluted with water(20 mL) and extracted with diethyl ether (2 ×10 mL) and ethyl acetate(3 ×10 mL). The combined organic layers were dried over Na2SO4, filtered and evaporated under reduced pressure. The crude material was purified by column chromatography on silica gel with pentane/diethylether (100:0 to 70:30) as eluent to afford the pure title compound
Reference: [1] Journal of Fluorine Chemistry, 2017, vol. 203, p. 155 - 165
  • 24
  • [ 41288-96-4 ]
  • [ 75-46-7 ]
  • [ 1206980-28-0 ]
YieldReaction ConditionsOperation in experiment
48%
Stage #1: With potassium hydroxide In water for 0.5 h;
Stage #2: at 20℃; for 3 h;
General procedure: Using an apparatus previously described for method B
[21]
, potassium hydroxide (2.52 g, 45 mmol, 15 equiv) and water (2.52 g) were added to the reaction vessel and the mixture was allowed to stir until the potassium hydroxide was almost completely dissolved.
Then, 2-bromo-3-pyridinol (0.354 g, 3 mmol) was added and the mixture stirred for 30 min, after which acetonitrile (10 mL) was added via syringe and the mixture stirred at room temperature.
Fluoroform was then bubbled slowly into the mixture for 2 h, after which the resulting mixture was stirred for one additional hour.
After being quenched with water and extracted with ethyl acetate, the ethyl acetate layer was washed with a saturated solution on sodium hydroxide, separated and concentrated.
Additional impurities were removed via column chromatography on silica gel using an 80:20 mixture of hexanes/methylene chloride to give a 53percent yield of the liquid product, 2-bromo-3-difluoromethoxypyridine (3d):
Reference: [1] Journal of Fluorine Chemistry, 2014, vol. 168, p. 34 - 39
  • 25
  • [ 41288-96-4 ]
  • [ 1206980-28-0 ]
Reference: [1] Chemistry - A European Journal, 2016, vol. 22, # 6, p. 2075 - 2084
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 41288-96-4 ]

Chlorides

Chemical Structure| 54232-03-0

[ 54232-03-0 ]

6-Chloro-5-methylpyridin-3-ol

Similarity: 0.85

Chemical Structure| 218770-02-6

[ 218770-02-6 ]

6-Chloro-2-methylpyridin-3-ol

Similarity: 0.85

Chemical Structure| 138084-65-8

[ 138084-65-8 ]

4-Amino-6-chloropyridin-3-ol

Similarity: 0.80

Chemical Structure| 52764-11-1

[ 52764-11-1 ]

2,6-Dichloropyridin-3-ol

Similarity: 0.80

Chemical Structure| 883107-68-4

[ 883107-68-4 ]

6-Chloro-2-fluoropyridin-3-ol

Similarity: 0.78

Alcohols

Chemical Structure| 54232-03-0

[ 54232-03-0 ]

6-Chloro-5-methylpyridin-3-ol

Similarity: 0.85

Chemical Structure| 218770-02-6

[ 218770-02-6 ]

6-Chloro-2-methylpyridin-3-ol

Similarity: 0.85

Chemical Structure| 138084-65-8

[ 138084-65-8 ]

4-Amino-6-chloropyridin-3-ol

Similarity: 0.80

Chemical Structure| 52764-11-1

[ 52764-11-1 ]

2,6-Dichloropyridin-3-ol

Similarity: 0.80

Chemical Structure| 883107-68-4

[ 883107-68-4 ]

6-Chloro-2-fluoropyridin-3-ol

Similarity: 0.78

Related Parent Nucleus of
[ 41288-96-4 ]

Pyridines

Chemical Structure| 54232-03-0

[ 54232-03-0 ]

6-Chloro-5-methylpyridin-3-ol

Similarity: 0.85

Chemical Structure| 218770-02-6

[ 218770-02-6 ]

6-Chloro-2-methylpyridin-3-ol

Similarity: 0.85

Chemical Structure| 138084-65-8

[ 138084-65-8 ]

4-Amino-6-chloropyridin-3-ol

Similarity: 0.80

Chemical Structure| 52764-11-1

[ 52764-11-1 ]

2,6-Dichloropyridin-3-ol

Similarity: 0.80

Chemical Structure| 883107-68-4

[ 883107-68-4 ]

6-Chloro-2-fluoropyridin-3-ol

Similarity: 0.78